BACKGROUND: Although a number of acute stroke interventions are of proven efficacy, there is uncertainty about their community benefits. We aimed to assess this within a defined population. METHODS: Eligibility for tissue plasminogen activator (tPA), aspirin, stroke unit management and neuroprotection were assessed among incident stroke cases within the community-based North East Melbourne Stroke Incidence Study. RESULTS: Among 306,631 people, there were 645 incident strokes managed in hospital. When eligible patients were extrapolated to the Australian population, for every 1,000 cases, 46 (95% CI 17-69) could have been saved from death or dependency with stroke unit management, 6 (95% CI 1-11) by using aspirin, 11 (95% CI 5-17) or 10 (95% CI 3-16) by using tPA at 3 and 6 h, respectively. CONCLUSIONS: Although tPA is the most potent intervention, management in stroke units has the greatest population benefit and should be a priority.
BACKGROUND: Although a number of acute stroke interventions are of proven efficacy, there is uncertainty about their community benefits. We aimed to assess this within a defined population. METHODS: Eligibility for tissue plasminogen activator (tPA), aspirin, stroke unit management and neuroprotection were assessed among incident stroke cases within the community-based North East Melbourne Stroke Incidence Study. RESULTS: Among 306,631 people, there were 645 incident strokes managed in hospital. When eligible patients were extrapolated to the Australian population, for every 1,000 cases, 46 (95% CI 17-69) could have been saved from death or dependency with stroke unit management, 6 (95% CI 1-11) by using aspirin, 11 (95% CI 5-17) or 10 (95% CI 3-16) by using tPA at 3 and 6 h, respectively. CONCLUSIONS: Although tPA is the most potent intervention, management in stroke units has the greatest population benefit and should be a priority.
Authors: Geoffrey A Donnan; Stephen M Davis; Mark W Parsons; Henry Ma; Helen M Dewey; David W Howells Journal: Nat Rev Neurol Date: 2011-06-14 Impact factor: 42.937
Authors: Eva Zupanic; Mia von Euler; Bengt Winblad; Hong Xu; Juraj Secnik; Milica Gregoric Kramberger; Dorota Religa; Bo Norrving; Sara Garcia-Ptacek Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Leonard Baatiema; Michael Otim; George Mnatzaganian; Ama De-Graft Aikins; Judith Coombes; Shawn Somerset Journal: BMC Health Serv Res Date: 2017-02-02 Impact factor: 2.655
Authors: Christine L Paul; Christopher R Levi; Catherine A D'Este; Mark W Parsons; Christopher F Bladin; Richard I Lindley; John R Attia; Frans Henskens; Erin Lalor; Mark Longworth; Sandy Middleton; Annika Ryan; Erin Kerr; Robert W Sanson-Fisher Journal: Implement Sci Date: 2014-03-25 Impact factor: 7.327
Authors: Eva Zupanic; Ingemar Kåreholt; Bo Norrving; Juraj Secnik; Mia von Euler; Bengt Winblad; Dorota Religa; Milica Gregoric Kramberger; Kristina Johnell; Maria Eriksdotter; Sara Garcia-Ptacek Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472